The total variation in the measurements of one or more specimens from one person is subject to both inherent biologic variation and analytic error. The biologic variation is estimated by analyzing multiple specimens from the same person. The analytic variation is usually estimated from repeated measurements of quality-control samples and of a single specimen. The best
StatIstIcal Methods Total lntraindMdualVariation (CVT)
The total variation in the measurements of one or more specimens from one person is subject to both inherent biologic variation and analytic error. The biologic variation is estimated by analyzing multiple specimens from the same person. The analytic variation is usually estimated from repeated measurements of quality-control samples and of a single specimen. The best mended CVa goals are 3% for TC (3), 6% for HDLC, 4% for LDLC, and 5% for TG (4). A goal for minimizing effects of CVb on CVT of mean lipid values has not been officially accepted. At present, it seems reasonable to propose a goal that can be practically met for most individuals with two specimens; this is the number of specimens used by most clinicians and laboratorians.
The biologic goal selected is to decrease the subject's CVT of the mean of serial specimens to the population average CVb (subject CVT population mean CVb). The current best estimate of the population mean CVb is the value found by metaanalysis of previous publications (2). This goal is consistent with the recommendation of NCEP Adult Treatment Panels I and II, that the average of at least two measurements be used for clinical decisions.
Results

Variation Factors of CV-,-on Mean Values of Serum Lipids and Lipoproteins
The effect of multiple specimens and analytic replicate measurements on CVT of the determined mean value is shown in Table 1 
RR Determinationfor a Selected Mean and CVT
We define RB as the difference between the lowest and highest concentration values observed for a person, divided by the mean of all the observed values. Expressing the difference between the values on a relative basis (percent difference) is useful, since the variability of specimen often increases with increasing concentration. We determined the distribution and 95th percentile value of RB values for a selected mean and CVT by performing a Monte Carlo simulation for a selected CV,. and CVb. We generated 10000 pairs of random observations from a gaussian distribution on the basis of a specified CVb and (Na combination for each analyte (corresponding to CVT) and NS (two to five specimens from each subject). From these data, we calculated the distribution of the RB. The RB upper 95% tolerance limit was estimated as the 95th percentile of the RB distribution. This 95% tolerance limit is the cutoff point below which the subject's measured RB value should fall in 95% of the replicate analyses, given a speCified and CVb. if one assumes that the (Na is correct, an observed RB value exceeding the 95th percentile tolerance limit implies higher biologic variability than expected.
Qualitative Assessment by AR Values
If the observed RB from a subject exceeds the RR 95% tolerance limit, then the person's biologic CVb may be high, assuming standardized analytic measurements. To obtain a more precise estimate of the mean concentration, one must measure one or more additional specimens. Once an additional specimen has been measured, the RE should be recalculated to determine if it falls within expected variation limits.
Proposed Specifications for Analytic Error and Biologic Variation for Upid and Upoprotein Measurements
The analytic goals for CVa in this study are the NCEP-approved goal for TC (3) and NCEP-recommended goals established by NCEP Lipoprotein Measurement Working Group, pending official approval by the NCEP Coordinating Committee (4). These analytic goals are considered attainable in well-controlled laboratories with existing methodology.
The NCEP-recom- is indicated by the RB, clinicians should collect additional specimens to measure the mean of the lipids within a proposed goal with 95% probability.
Reliable estimates of the subject's average lipid values thus may require measurements on repeat specimens.
We selected the RR as a surrogate indicator of the effect of the biologic variation on accuracy of mean value because it is convenient, is easily understood, and has a known relation to SD (15). It also adjusts the total variation for the expected increase in difference of values as the mean concentration increases.
The range of quality-control measurements has been used for -40 years as a measure of analytic precision in clinical laboratory procedures (16). In control reference materials, range values reflect the concentration and the precision of the analytic diagnostic system. In serial specimens from the same person, the range of reported values is a function of effect of biologic concentration and variation as well as of analytic precision. BR therefore is applicable to estimation of effect of biologic variation on the mean value if the analytic error is known or is estimated for the laboratory analytic system. The BR determined from a limited number of specimens does not provide a highly accurate assessment of the CVT. However, we believe that this is offset for the following reasons:
First, the RB focuses attention on biologic variation and, at a minimum, requires two specimens, reducing sizeably the measurement error (SD) by
iiV.
Second, even in the case of lower-than-average biologic variation, samples can vary at random considerably; for example, one sample result could be statistically low (in the lower tail of the distribution) and the next statistically high (in the upper tail). The RB therefore has a good chance of detecting this situation and would require collecting an additional specimen that is likely to yield a more representative value. The CVT, when mean values are involved, is related toCVb as shown in Eq. 1. Because CVb makes an inherent, relatively stable contribution to the variability of a person's true lipid serum concentration, the contribution of CVb to the intraindividual lipid variation can be decreased only indirectly through factors that can affect the T.
By increasing NS, the contribution of CVb to
CVT is decreased and, with a sufficient number of specimens, the CVT can be decreased to meet the goal of CVT mean CVb. The equation for CVT also shows that the contribution of CV,. can be decreased by increasing both NS and NR; however, increasing the latter is not as efficient as increasing NS. Table 1 illustrates the changes exerted on total CVT by decreasing the contribution of CVb through increasing NS from the same subject, a procedure that is more useful when (Nb is large.
To determine if a patient's biologic variation is excessive, a clinician or laboratorian can quickly calculate RB from the difference (range) of two specimens (or more), divide by average of the specimens, compare with the appropriate RR in Table 2 , and if the calculated BR is less than the respective upper limit, be assured with 95% probability that the determined mean value lies within the CVT based on upper-limit analytic and biologic variation goals. The previously published results on TC (1) are slightly different from the first column of Table 2 because CVb of 6.1% from met.aanalysis is used instead of 6.5% previously, and additional simulations were done to improve accuracy. Different levels of (mean) biologic variation may be postulated for experimentally controlled study types as well as for randomly selected individuals. For example, studies in which the subject's diet is carefully controlled probably yield lower (mean) CVb and corresponding
T
and RR values than studies in which diet is not controlled.
To help evaluate this effect on the specimen requirements, one can show CVT (ordinate) as a function of the CVb range (Fig. 1A-D) and demonstrate the effect of the number of measured specimens for TC, HDLC, LDLC, and TG. The CV,. for each figure is the NCEP tentative analytic goal (pending approval) (17) listed in Table 1 ; we assume one laboratory measurement per specimen.
The abscissa of each figure corresponds to the range of CVbs found among studies in the metaanalysis (2); the vertical line is positioned at the mean CVb. It indicates the current best estimate of an average person's inherent biologic variation. Using Fig. LA 
